锂可以给予接受血液透析治疗的患者。

[Lithium can be given to patients on haemodialysis treatment].

作者信息

Kancir Anne Sophie Pinholt, Viftrup Jens Emil, Pedersen Erling Bjerregaard

机构信息

Medicinsk Forskning og Universitets-klinikken i Nefrologi og Hypertension, Regionshospitalet Holstebro, Lægårdvej 12, 7500 Holstebro.

出版信息

Ugeskr Laeger. 2015 Jan 26;177(2A):60-1.

PMID:25612969

Abstract

Lithium-induced nephropathy is a known complication of lithium treatment in bipolar disorder. Treatment with lithium should be discontinued, if there is evidence of lithium-induced nephropathy. However, lithium can be given to patients with end-stage-renal-disease on haemodialysis treatment, if there is no other way to control the bipolar disorder. We report one patient who was successfully treated with lithium in parallel with haemodialysis.

摘要

锂诱导的肾病是双相情感障碍锂治疗已知的并发症。如果有锂诱导肾病的证据，应停用锂治疗。然而，如果没有其他方法控制双相情感障碍，锂可给予接受血液透析治疗的终末期肾病患者。我们报告了一例在血液透析同时成功接受锂治疗的患者。